Results 151 to 160 of about 2,415,366 (239)

Household contact management for rifampicin-resistant tuberculosis

The Lancet Global Health, 2022
Anja Reuter, Ivy Apolisi, Johnny Daniels, Jennifer Furin, Helen Cox   +4 more
openaire   +3 more sources

Airborne Immunity: A Bacterial Volatile Primes Plant Defenses by Unlocking a Phytoalexin Biosynthetic Checkpoint

Plant, Cell &Environment, Volume 49, Issue 11, Page 9070-9084, November 2026.
ABSTRACT Microbial volatile organic compounds (mVOCs) enable plants to perceive microbial activity prior to physical contact, yet the contribution of individual bacterial volatiles to immune signalling and disease resistance remains incompletely understood.
Ivan A. Paponov, Chidananda Nagamangala Kanchiswamy, Simone Bossi, Francesco Caldo, Ambra S. Parmagnani, Mickael Malnoy, Massimo E. Maffei   +6 more
wiley   +1 more source

An efficient gene delivery method utilizing the regenerative capacity of alfalfa (Medicago sativa)

The Plant Journal, Volume 128, Issue 3, November 2026.
SUMMARY Alfalfa (Medicago sativa), an autotetraploid species, is a globally important forage crop. Traditional genetic transformation methods predominantly rely on leaf‐derived callus, a process that is complex, inefficient, and particularly challenging to generate stable transgenic lines in polyploid plants.
Jinghui Gao, Houyin Xia, Yajun Wu, Changgen Xie, Jiawen Peng, Yilin Cui, Yiyang Liu, Luna Tan, Chun Li, Qian Li, Jie An, Peizhi Yang   +11 more
wiley   +1 more source

Brucella abortus RB51 Persistent Infection and Milk Shedding in Vaccinated Dairy Cattle: A Public Health Risk

Zoonoses and Public Health, Volume 73, Issue 7, Page 601-605, November 2026.
ABSTRACT Introduction Brucellosis, caused by a group of bacteria within the genus Brucella, is a zoonotic disease of significant public health concern. The RB51 strain vaccine is used to combat cattle brucellosis but has potential health consequences for exposed humans.
Elizabeth S. Hines, Sara F. Margrey, Stephanie W. Cox, Christine Quance, Tyler C. Thacker, Patricia L. Collins, Susan Rollo, Leslie L. Bulaga‐Seraphin, Aimee Hunt, Gary Stevens, Kyran Cadmus, Maria Negron, Grishma Kharod, Rebekah Tiller, Suelee Robbe‐Austerman, Jason E. Lombard   +15 more
wiley   +1 more source

Synthesis, Characterization, and In Vitro Evaluation of New Amino‐Alcohol Quinolines as Promising Antimycobacterial Agents

ChemMedChem, Volume 21, Issue 20, 28 October 2026.
Nontuberculous mycobacteria (NTM) mainly Mycobacterium avium complex (MAC), are emerging pathogens responsible for pulmonary infections. The efficacy of the standard treatment is therefore compromised by the emergence of intrinsic and acquired resistance in MAC.
Elise Si Ahmed Charrier, François Peltier, Jean‐François Raimbert, Marie Perret, Claire Andréjak, Alexandra Dassonville‐Klimpt, Pascal Sonnet   +6 more
wiley   +1 more source

The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995)

, 1998
Methicillin-resistant Staphylococcus aureus (MRSA) is endemic in teaching hospitals in eastern Australian states, with prevalence rates averaging 25-30% of all S.aureus.
Gottlieb, T., Australian Group for Antimicrobial Resistance,, Mitchell, D.   +2 more
core  

4‐Thiazolidinone/2,4‐Thiazolidinedione–Sulfonamide Hybrids: A Concise Review of Their Design and Pharmacological Significance

ChemMedChem, Volume 21, Issue 20, 28 October 2026.
Sulfonamide–thiazolidinone hybrids integrate complementary pharmacophores to generate multifunctional scaffolds with broad pharmacological potential. Their structural versatility supports antimicrobial, antifungal, antioxidant, anticancer, anti‐inflammatory, antidiabetic, anticonvulsant, and enzyme‐inhibitory activities.
Subham Kumar Vishwakarma, Andressa Francielli Bonjorno, Sukhwant Singh, Christian S. Carnero Canales, Jean Leandro dos Santos, Cesar Augusto Roque‐Borda, Fernando Rogério Pavan   +6 more
wiley   +1 more source

Clinical and laboratory determinants of treatment response and rifampicin resistance among Xpert MTB/RIF-confirmed extrapulmonary tuberculosis patients: A prospective study from Central India. [PDF]

PLoS One
Bhagwat G, Kanthali M, Chauhan S, Julka A, Chauhan DS, Purohit M.   +5 more
europepmc   +1 more source

Burden of Rifampicin Resistance Among Patients With Tuberculosis at a Tertiary Care Center in Uttarakhand, India: A Prospective Cross-Sectional Study. [PDF]

Cureus
Negi S, Singh M, Chandola I, Rawat J.
europepmc   +1 more source

Analysis of rpoB mutations associated with rifampicin resistance in Mycobacterium tuberculosis isolates in Malawi. [PDF]

BMC Infect Dis
Soko S, Kumwenda P.
europepmc   +1 more source